Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3

In vivo tests were performed to assess the influence of the protease inhibitor TL-3 on feline immunodeficiency virus (FIV)-induced central nervous system (CNS) deficits. Twenty cats were divided into four groups of five animals each. Group 1 received no treatment, group 2 received TL-3 only, group 3...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Huitron-Resendiz, Salvador, de Rozières, Sohela, Sanchez-Alavez, Manuel, Bühler, Bernd, Lin, Ying-Chuan, Lerner, Danica L., Henriksen, Nicholas W., Burudi, Mboya, Fox, Howard S., Torbett, Bruce E., Henriksen, Steven, Elder, John H.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2004
Matèries:	Vaccines and Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC387718/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15078933/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.9.4525-4532.2004
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!